Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025

attenuates acute lung injury by regulating the differentiation and function of myeloid-derived suppressor cells.

View Full Paper
Ask AI
Bookmark
Share

Authors

LWLingyu WeiTSTong ShuMWMinghui Wang

Discussion

Loading...

Member takes

Overview

Experimental analysis reveals TW reduces myeloid-derived suppressor cells and cytokine levels in acute lung injury models, suggesting a potential therapeutic role.

Key Points

  • TW treatment significantly improved lung injury outcomes compared to LPS exposure, reducing inflammation and injury severity.
  • Histopathological scoring showed severe lung damage in the LPS group, while TW treatment resulted in improved scores (P<0.05).
  • Cytokine levels like IL-6 and TNF-α were lower in the LPS+TW group versus the LPS group, indicating anti-inflammatory effects.
  • Flow cytometry demonstrated reduced MDSC proportions in lung tissues with TW treatment, potentially enhancing immune response.

Cite This Study

Wei et al. (2025) studied this question.

synapsesocial.com/papers/68c23d81b210217d6478dfaahttps://doi.org/10.11817/j.issn.1672-7347.2025.240424
View Full Paper
Ask AI
Bookmark
Share